This review will discuss the evidence regarding how various environmental risk factors, such as infections agents and physical trauma, can lead to neuropathological changes by disrupting autophagy in ALS and potential treatment options in the management of each environmental factor previously discussed.
Increasing evidence suggests that PD has a multifactorial etiology involving complex interactions between genetic and environmental factors that may as yet be unidentified.
Evidence continues to mount in support of TUDCA's potential clinical application as part of a therapeutic approach to the treatment of neuroinflammatory and neurodegenerative conditions.
Evidence continues to mount in support of TUDCA's potential clinical application as part of a therapeutic approach to the treatment of neuroinflammatory and neurodegenerative conditions.
Evidence continues to mount in support of TUDCA's potential clinical application as part of a therapeutic approach to the treatment of neuroinflammatory and neurodegenerative conditions.